Higher doses of dopamine agonists, impulse control disorders and history of deep brain stimulation (DBS): Risk factors for dopamine agonists withdrawal syndrome (DAWS)?
Objective: To identify risk factors in the development of DAWS in patients with Parkinson's disease (PD). Background: DAWS is often a severe, stereotyped cluster of…The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder
Objective: Assess the relation between dream content and non-motor symptoms in Parkinson's disease (PD) and idiopathic REM sleep behavior disorder (iRBD). Background: Although a link…Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)
Objective: To identify nocturnal symptoms in patients which lead to sleep deprivation in carers of PD patients. Background: SD affects the health status of the…Non-motor symptoms (NMS) as a determinant of caregiver burden in a cohort of older patients with Parkinson’s disease (PD)
Objective: The main goal of this study was to assess the impact of NMS burden and severity on Caregiver Burden in a cohort of older…Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients
Objective: To evaluate the prevalence of non-motor symptoms in p.A53T α-synuclein (SNCA) related Parkinson's disease (PD) as compared to sporadic Parkinson's disease (sPD) patients. Background:…Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2
Objective: To evaluate the relationship between fatigue and sleep disturbances in patients with Parkinson's disease (PD). Background: In patients with PD, fatigue is an important…Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study
Objective: The aim of the present study was to determine the effects of istradefylline, adenosine A2A receptor antagonist on lower urinary tract symptoms (LUTS) in…Exercise induced analgesia is present in people with Parkinson’s disease
Objective: To investigate if exercise-induced analgesia (EIA) is present in people with Parkinson's disease (PD) compared to an age-matched control group. Background: Pain is a…Motor features and response to levodopa in Parkinson’s disease with normal olfactory function
Objective: The aim of this study was to evaluate motor features in the OFF and ON states and the acute levodopa response in Parkinson's disease…The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration
Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.